A Study to Describe the Effect of a Combined Vaccine Against RSV and COVID-19 (Substudy A)
Substudy A (SSA): A Phase 1/2 Substudy to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Vaccine
Candidate(s) Against Infectious Respiratory Illnesses, Including COVID-19 and RSV, in Healthy Individuals
Category & Conditions: Vaccine-related Conditions
Medicine: RSV & modRNA COVID-19 Combination
ClinicalTrials.gov Identifier (NCT): NCT05886777
Protocol ID: C5481001 Substudy A
Open Plain Language Summary Result:
Click here